Feature

Astrocyte delivering first-in-class approach to brain injury neuroprotection

Closely held Astrocyte Pharmaceuticals is developing a new category of neuroprotective therapies aimed at reducing early brain damage following stroke, concussion, and traumatic brain injury (TBI). By harnessing the...

February 3, 2026

Feature

First Ascent changing the cancer care narrative with functional precision medicine

Closely held First Ascent Biomedical is working to redefine how oncologists select therapies by pairing genomics with a proprietary live-cell testing platform that evaluates how an individual patient’s cancer responds...

January 20, 2026

Feature

In conversation with Leslie Loveless, CEO and managing partner of Slone Partners

For more than two decades, Slone Partners has maintained a dedicated focus on leadership recruitment for life sciences and healthcare organizations. The company’s co-CEO and managing partner, Leslie Loveless, has been...

January 13, 2026

Feature

PetVivo improving the lives of pets and athlete animals through joint health and mobility

PetVivo Holdings (PetVivo Animal Health) (OTCQX: PTEV; OTCID: PETVW) is adapting human regenerative therapies for the management of osteoarthritis (OA) and other joint disorders in companion and athlete animals. The...

January 6, 2026

NEWS

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

Astrocyte delivering first-in-class approach to brain injury neuroprotection

First Ascent changing the cancer care narrative with functional precision medicine

In conversation with Leslie Loveless, CEO and managing partner of Slone Partners

PetVivo improving the lives of pets and athlete animals through joint health and mobility

NEWS

The Journal, Heart Failure, publishes results from Cardiol’s Phase 2 ARCHER study

BioSyent to acquire Oral Science

BioRestorative completes landmark Phase 2 enrollment for BRTX-100 in cLDD; advances toward Phase 3 and BLA

PreveCeutical files patent for delivery of CNS-active agents

Rita Johnson-Greene joins Ocugen as CFO

Exicure reports publication highlighting Phase 2 burixafor data showing rapid stem cell mobilization

Cognition lengthens Zervimesine program in DLB

PRO FAMILIA and Profound mark 500 Sonalleve Procedures; expand access to incision-free women’s healthcare

JPO grants patent to Marvel for MB-204

Just a few of the companies we’ve highlighted along the way

Subscribe